EBT-101 is a potentially curative, one-time CRISPR-based treatment which makes two cuts in integrated retroviral DNA to remove large portions of the HIV genome and prevent HIV from escaping and ...
SAN FRANCISCO, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Excision BioTherapeutics, Inc., a clinical-stage biotechnology company developing CRISPR-based therapies intended to cure viral infectious diseases, ...
LANSING, Mich. (WLNS) — In the 1980s and 90s, the word AIDS — Acquired Immuno-Deficiency Syndrome — conjured up images of skeletal people dying. It was a constellation of infections that killed people ...
Excision Biotherapeutics’ groundbreaking HIV treatment, EBT-101, was approved by the Food and Drug Administration to begin testing for its first phase of human trials. This new treatment relies on the ...
INDIANAPOLIS (WISH) — Friday is National HIV Testing Day. Experts use this day as a day of advocacy and to encourage people to learn about the infection, explain what testing looks like, and to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results